- 收听数
- 0
- 性别
- 保密
- 听众数
- 14
- 最后登录
- 2024-1-22
- QQ
 - UID
- 32923
- 阅读权限
- 10
- 帖子
- 138
- 精华
- 0
- 在线时间
- 43 小时
- 注册时间
- 2020-11-24

- 科研币
- 0
- 速递币
- 170
- 娱乐币
- 2787
- 文献值
- 1
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | A randomised Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon-like peptide-1 receptor agonist, in healthy Japanese men with overweight/obesity | 链接 | https://pubmed.ncbi.nlm.nih.gov/36974349/ |
|
|